🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lucas C. Zarling

University of Wisconsin Carbone Cancer Center

ORCID: 0000-0003-3557-2351

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation”.

Contribution of measurable residual disease status to prediction accuracy of relapse and survival in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

Haematologica(2022)10.3324/haematol.2022.281631

N/A

0.470DataRank · unranked

22 citations

Megan Othus, Corentin Orvain, Lucas C. Zarling, Brenda M. Sandmaier, Filippo Milano +7 more

Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic Sensitivity

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.15.464556

N/A

0.345DataRank · unranked

9 citations

Shujah Rehman, Katherine A. Johnson, Amani A. Gillette, Aishwarya Sunil, Peter F. Favreau +29 more

Sensitivity of HER2-amplified colorectal organotypic cancer spheroids at ex vivo resistance to panitumumab and trastuzumab.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.68

N/A

0DataRank · unranked

0 citations

Lucas C. Zarling, Aishwarya Sunil, Shujah Rehman, Katherine A. Johnson, Sarbjeet Makkar +8 more